María Erendira
Calleja Cervantes
Bioinformática
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (5)
2019
-
Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program
Acta Neuropathologica, Vol. 138, Núm. 6, pp. 1053-1074
-
Epigenetic loss of the endoplasmic reticulum-associated degradation inhibitor SVIP induces cancer cell metabolic reprogramming
JCI Insight, Vol. 4, Núm. 8
-
The altered transcriptome and DNA methylation profiles of docetaxel resistance in breast cancer PDX models
Molecular Cancer Research, Vol. 17, Núm. 10, pp. 2063-2076
-
The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition
Nature Communications, Vol. 10, Núm. 1
2018
-
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
The Lancet Respiratory Medicine, Vol. 6, Núm. 10, pp. 771-781